The two prominent diseases i.e Cancer and HIV infections has been putting a challenge to researchers community to find a reliable treatment. There have been newer developments and research advances in finding the cure for these by using chemistry biology interface research. To collect the advances in the filed, a special issue on anti-cancer and anti-HIV therapeutics development would be published in Chemical Biology Letters. The issue will cover the themes (though not limited to as field and research is wide):
– Kinase Inhibitor advances
– new targets for anti-cancer molecules
– development in anti-HIV therapeutics
– Medicinal Chemistry of Anti-Cancer drugs
– Medicinal Chemistry of anti – HIV molecules
– Development in drug delivery systems for anti-cancer and anti-HIV drugs
– Peptides based drug delivery
– Peptide therapeutics
– targeted drug delivery
– Small molecules and Heterocyclic molecules for anti-cancer and anti-HIV therapy
The Medicinal Chemistry community is invited to contribute a ‘Review Article’ ‘Research Article’ or ‘Short Communication’ for processing in special issue.
Submission: The manuscript should be prepared as per details provided on Author Guidelines page: http://pubs.thesciencein.org/author-guidelines-chemical-biology-journal/
The article should be submitted online on the journal site at http://pubs.thesciencein.org/journal/index.php/cbl
Last date for submission of manuscript: November 30, 2018.
Edited by
Prof. Keykavous Parang Associate Dean of Research, Graduate Studies, and Global Affairs Professor of Medicinal Chemistry and Pharmacology Harry and Diane Rinker Health Science Campus 9401 Jeronimo Rd. Irvine, CA 92618-1908. USA Email: parang@chapman.edu |
Dr. Rakesh Tiwari Chapman University School of Pharmacy (CUSP) Harry & Diane Rinker Health Science Campus 9501 Jeronimo Road Rm 241 Irvine, CA 92618 Email: tiwari@chapman.edu |
Chemical Biology Letters is indexed in SCOPUS, CAS, CNKI, Google Scholar and other popular indexing databases.